PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.\', \'MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.\', \'Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, United Kingdom.\', \'Institut für Biologische Physik, Universität zu Köln, Köln, Germany.\', \'Department of Medicine, University of Cambridge, Cambridge, United Kingdom.\', \'Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.\', \'Public Health England Field Epidemiology Unit, Cambridge Institute of Public Health, Cambridge, United Kingdom.\', \'Department of Pathology, Division of Virology, University of Cambridge, Cambridge, United Kingdom.\', \'Clinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.\', \'Francis Crick Institute, London, United Kingdom.\', \'Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge, United Kingdom.\', \'Wellcome Sanger Institute, Hinxton, United Kingdom.\', \'MRC Epidemiology Unit, University of Cambridge, Level 3 Institute of Metabolic Science, Cambridge, United Kingdom.\', \'School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.\', \'Public Health England, National Infection Service, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • msac02510.1093/molbev/msac025
?:doi
?:hasPublicationType
?:journal
  • Molecular biology and evolution
is ?:pmid of
?:pmid
?:pmid
  • 35106603
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.475
?:rankingScore_hIndex
  • 190
?:title
  • A2B-COVID: A Tool for Rapidly Evaluating Potential SARS-CoV-2 Transmission Events.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all